UNSPSC 51192600: Combination protective agents

This classification denotes combination drugs and preparations which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent, so, as in the case of chemotherapy treatment which causes damage to kidneys or other organs, such PROTECTIVE AGENTS reduce said damage. Typical combination protective agent constituients are amifostine and mannitol.

UNSPSC 51192600 Combination protective agents is a Class code under which state and local governments procure generic pharmaceuticals and over-the-counter products distributed through cooperative purchasing networks. Recent solicitations show state procurement agencies and multistate alliances buying manufactured pharmaceutical products—including generics and OTC items—with specified National Drug Codes, packaging configurations, and strength/dosage formulations, supplied through authorized wholesaler distribution channels. Vendors must meet FDA requirements, maintain current Good Manufacturing Practices (cGMP) certification, and comply with Drug Supply Chain Security Act (DSCSA) standards. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a notable repeat buyer under this code, managing contracts that serve participating state and local government facilities across multiple states including Oregon. Issuing bodies purchasing under this code span state health and human services departments, state procurement offices managing cooperative agreements, and the constituent local and state entities participating in multistate purchasing alliances.

MMCAP's January 2026 RFP for Generic Multi-Source Pharmaceuticals and OTC Products, due March 26, 2026, represents the most recent activity under this code. The solicitation establishes multiple manufacturer contracts effective July 1, 2026, requiring vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with evaluation weighted heavily on price competitiveness (75 percent) and administrative compliance (20 percent combined), and with contract terms of two years for new responders or extensions through June 30, 2028 for incumbents. Minnesota and the broader multistate cooperative purchasing region (including Oregon and other participating jurisdictions) represent the primary geographic concentration of recent activity under this code.